Format

Send to

Choose Destination
See comment in PubMed Commons below
Endocr Pathol. 2006 Fall;17(3):203-12.

Role of mitochondrial mutations in cancer.

Author information

1
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Graduate School of Public Health-Department of Human Genetics, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA. baysalb@mwri.magee.edu

Abstract

A role for mitochondria in cancer causation has been implicated through identification of mutations in the mitochondrial DNA (mtDNA) and in nuclear-encoded mitochondrial genes. Although many mtDNA mutations were detected in common tumors, an unequivocal causal link between heritable mitochondrial abnormalities and cancer is provided only by the germ line mutations in the nuclear-encoded genes for succinate dehydrogenase (mitochondrial complex II) and fumarate hydratase (fumarase). The absence of evidence for highly penetrant tumors caused by inherited mtDNA mutations contrasts with the frequent occurrence of mtDNA mutations in many different tumor types. Thus, either the majority of diverse mtDNA mutations observed in tumors are not important for the process of carcinogenesis or that they play a common oncogenic role.

PMID:
17308357
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center